28 results found.
Orthopedic Public Companies Grow 2.6% YoY in Quarter
By Mike Evers The second quarter of 2019 brought incremental improvement over the first. Year over year revenue grew 2.6% in the quarter for the public companies reported herein compared to 1.1% last quarter. The five largest orthopedic players, which control 58% of the market, showed a...
Implanet reports 2Q19 revenue of €1.9MM (USD $2.2MM), +8.4% vs. 2Q18
Implanet reports 2Q19 revenue of €1.9MM (USD $2.2MM), +8.4% vs. 2Q18, with 1H19 revenue of €3.8MM (USD $8.0MM), +5.2% vs. 1H18.
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Implanet reports 4Q18 revenue of €1.5MM (USD 1.8MM), -21.5% vs. 4Q17
Implanet reports 4Q18 revenue of €1.5MM (USD 1.8MM), -21.5% vs. 4Q17, with 2018 revenue of
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Implanet 1Q17 Revenue
Implanet reported 1Q17 revenue of €2.0MM (~US $2.2MM), -3.5% vs. 1Q16.
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
Implanet Reports 2016 and 4Q16 Revenue
Implanet posted 2016 revenue of €7.8MM (~US $8.6MM), +17.6% vs. 2015, with of 4Q16 revenue of
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
Implanet Reports 3Q16 Revenue
Implanet posted 3Q16 revenue of €1.4MM (~US $1.7MM), -11.6% vs. 3Q15.
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
Implanet Reports 2Q16 Revenue
Implanet posted 2Q16 revenue of €2.1MM (~US $2.3MM), +22.6% vs. 2Q15, as-reported.
Implanet Posts 1Q16 Revenue
Implanet reported 1Q16 revenue of €1.9MM (~US $2.3MM), +24.3% vs. 1Q15 as-reported.
Implanet Reports 2015 Revenue Up 6% vs. 2014
Implanet reported 2015 revenue of €6.6MM (~US $7.2MM), +6% vs. 2014 (excluding discontinued hip product sales)....
Company Revenue 2015: Implanet
Download the March issue of ORTHOKNOW for a graphical presentation of 2015 company performance. 2015: €6.6MM (~US $7.2MM)...
Implanet 3Q15 Growth +42% vs. 3Q14
Implanet reported 3Q15 revenue of €1.69MM (~US $1.87MM), +42% from 3Q14, and YTD 2015 revenue of 
BARE BONES® - July 28, 2015
Implanet posted 1H15 revenue of €3.3MM (~US $3.6MM), +2.2% vs. 1H14. (Spine ~$1.6MM, +65.5%; Knee + Arthroscopy ~$2.0MM, -21.5%) (
BARE BONES® - April 28, 2015
Implanet posted 1Q15 revenue of €1.5MM (~US $1.8MM), -21.9% vs. 1Q14. (Spine ~$0.8MM, +77.6%; Knee + Arthroscopy ~$0.9MM, +-32.2%) (
BARE BONES® - January 7, 2015
Implanet posted 2014 revenue of €7.0MM (~US $8.3MM), +5% vs. 2013. (Spine ~$2.3MM, +138%; Knee + Arthroscopy ~$5.3MM, +6%; Hips ~$0.9MM, -57%) (
2014 Revenue: Implanet
2014 revenue €7.0MM (~US $8.31MM), +5% (excluding Hips, +28%); France ~$4.5MM, Export sales ~$3.4MM, U.S. ~$0.9MM Spine ~$2.28, +138% Knee + Arthroscopy ~$5.3MM Hip ~$0.9MM, -57%   4Q14 revenue €1.8MM (~...
BARE BONES® - October 27, 2014
Implanet reported 3Q14 revenue of €1,188MM (~US $1,509.35MM), -28% from 3Q13. (Spine/JAZZ Platform ~$499.31MM, +109%; Knee + Arthroscopy ~$1,010.05MM, -26%) (
3Q14 Revenue: Implanet
€1,188MM (~US $1,509.35MM), -28% Spine/JAZZ Platform ~$499.31MM, +109% Knee + Arthroscopy ~$1,010.05MM, -26% Knee ~$793.3MM, +69% Arthroscopy ~$195.2MM, -78%   ...
BARE BONES® - July 29, 2014
IMPLANET posted 1H14 revenue of €4.0MM (~US $5.3MM), +21% vs. 1H13. (Hips ~$1.0MM, -22%; Knee + Arthroscopy ~$3.1MM, +20%; Spine ~$1.1MM, +131%) (
2Q14 Revenue: Implanet
(1H revenue only) €4.0MM (~US $5.3MM), +21% Hips ~$1.0MM, -22% Knee + Arthroscopy ~$3.1MM, +20% Spine ~$1.1MM, +131%   2,174 JAZZ units sold YTD (exceeding 2013 total of 1,953), >...
BARE BONES® - April 28, 2014
IMPLANET posted 1Q14 revenue of €2.0MM (~US $2.8MM), +7% vs. 1Q13. (Hips ~$0.5MM, -32%; Knee + Arthroscopy ~$1.7MM, +11%; Spine ~$0.6MM, +79%) (
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group